# DO NOT MODIFY THIS FILE, it was auto-generated.
#
# Date: 2015-09-04 14:30:01 -0700
# Seeding ClinicalTrial
# Written with the command:
#
#   create_seed_files.rb 
#
ClinicalTrial.seed(:nct_id,
  {:initial_database_id=>"178", :nct_id=>"NCT02221622", :pi_name=>"Roberta Brinton", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/178", :title=>"Allopregnanolone Regenerative Therapeutic for MCI/AD: Dose Finding Phase I", :hashtags=>["#Alzheimer", "#Alzheimers", "#dementia", "#AlzFacts", "#GlobalDementia"], :disease=>"Alzheimer"},
  {:initial_database_id=>"114", :nct_id=>"NCT02008357", :pi_name=>"Lon Schneider", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/114", :title=>"Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)", :hashtags=>["#Alzheimer", "#Alzheimers", "#dementia", "#AlzFacts", "#GlobalDementia"], :disease=>"Alzheimer"},
  {:initial_database_id=>"148", :nct_id=>"NCT01756729", :pi_name=>"Thomas Chen", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/148", :title=>"6G-13-1-A Prospective, Non-Randomized, Concurrent Control, Open Label, Post-Approval Study Of NovoTTF-100A In Recurrent GBM Patients", :hashtags=>["#BrainCancer", "#BrainTumor"], :disease=>"Brain Cancer"},
  {:initial_database_id=>"301", :nct_id=>"NCT01535066", :pi_name=>"Dawn Hershman", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/301", :title=>"Randomized Blinded Sham- and Waitlist-Controlled Trial of Acupuncture for Joint Symptoms Related to Aromatase Inhibitors in Women With Early Stage Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"186", :nct_id=>"NCT01872975", :pi_name=>"Eugene Chung", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/186", :title=>"CTSU_NSABP-51/RTOG 1304 - A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and  - Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"196", :nct_id=>"NCT02067884", :pi_name=>"Linda Larsen", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/196", :title=>"1B-13-8 Real Time Contrast Enhanced Ultrasound and Ultrasound-Based Elastography: Novel Techniques in Assessment of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"300", :nct_id=>"NCT01272037", :pi_name=>"Julie Gralow", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/300", :title=>"A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"141", :nct_id=>"NCT02032277", :pi_name=>"Christy Russell", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/141", :title=>"1B-14-1: A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvant Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer (TNBC)", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"138", :nct_id=>"NCT02091960", :pi_name=>"Agustin Garcia", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/138", :title=>"A Phase 2, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutamide with Trastuzumab in Subjects with HER2+ AR+ Metastatic or Locally Advanced Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"218", :nct_id=>"NCT01805076", :pi_name=>"Pulin Sheth", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/218", :title=>"Alliance A011104/ ACRIN6694 Effect of Preoperative Breast MRI on Surgical Outcomes,\r\nCosts and Quality of Life of Women with Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"112", :nct_id=>"NCT01997333", :pi_name=>"Darcy Spicer", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/112", :title=>"1B-13-10-A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer. (The METRIC Study)", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"290", :nct_id=>"NCT01670877", :pi_name=>"Cynthia Ma", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/290", :title=>"A Phase II Study of Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"287", :nct_id=>"NCT01873833", :pi_name=>"Agustin Garcia", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/287", :title=>"Phase II Trial of Metronomic Capecitabine and Cyclophosphamide With Lapatinib and Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-Based Regimen", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"230", :nct_id=>"NCT01649258", :pi_name=>"Agustin Garcia", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/230", :title=>"1B-11-5: A Pilot Study to Evaluate the Efficacy of  Fosaprepitant and Granisetron Transdermal System for the Prevention of Acute and Delayed Nausea and Vomiting in Breast Cancer Patients and to Identify Predictors of Response", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"302", :nct_id=>"NCT01674140", :pi_name=>"Mariana Chavez-MacGregor", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/302", :title=>"Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"232", :nct_id=>"NCT01901094", :pi_name=>"Heather MacDonald", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/232", :title=>"A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (CT1-3 N1) who Have Positive Sentinel Lymph Node Disease after Neoadjuvant Chemotherapy", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"321", :nct_id=>"NCT01712815", :pi_name=>"Peter Conti", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/321", :title=>"Development of an In Vivo Cell Proliferation Marker for PET Assessment of Chemotherapeutic Response in Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"142", :nct_id=>"NCT02048059", :pi_name=>"Agustin Garcia", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/142", :title=>"1B-14-2: A Phase II, Open-Label, Multi-Center Study of ANG1005 in Breast Cancer Patients with Recurrent Brain Metastases", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"299", :nct_id=>"NCT01111825", :pi_name=>"Puma Biotechnology", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/299", :title=>"A Phase I/II Trial of Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"153", :nct_id=>"NCT01755208", :pi_name=>"Jacques Van Dam", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/153", :title=>"1B-12-6 Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study", :hashtags=>["#BreastCancer", "#BRCA", "#BRCA1", "#BRCA2", "#advancedBC", "#metastaticBC", "#malebreastcancer", "#BCKills", "#DontIgnoreStageIV", "#MBCAware", "#MetsMonday", "#BCD2020"], :disease=>"Breast Cancer"},
  {:initial_database_id=>"107", :nct_id=>"NCT02150733", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/107", :title=>"0C-14-1 A Phase 1, Open-Label Study Assessing the Impact of Hepatic Impairment on the Pharmacokinetics of  Tivantinib in Subjects with Advanced Solid Tumors", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"29", :nct_id=>"NCT01576406", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/29", :title=>"0C-12-1-A Phase 1 Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety of Crizotinib in Advanced Cancer Patients [A8081012] ", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"100", :nct_id=>"NCT01986218", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/100", :title=>"0C-14-3: Phase I Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-986115 in Subjects with Advanced Solid Tumors", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"124", :nct_id=>"NCT02122146", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/124", :title=>"0C-14-5: A Phase 1, Dose Escalation Study of PF-06664178 In Patients with Locally Advanced or Metastatic Solid Tumors", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"296", :nct_id=>"NCT01873326", :pi_name=>"Darren Feldman", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/296", :title=>"Randomized Phase II Trial of Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-Risk Germ Cell Tumors", :hashtags=>["#GynCSM"], :disease=>"Gynaecological Cancer"},
  {:initial_database_id=>"291", :nct_id=>"NCT01621295", :pi_name=>"Jon Tilburt", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/291", :title=>"Assessing the Patient Experience in Cancer Care: An Observational Communication Study", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"211", :nct_id=>"NCT01534598", :pi_name=>"Heinz-Josef Lenz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/211", :title=>"0C-12-3: PhI-70 Phase I Trial of Oral 5-Fluoro-2-Deoxycytidine With Oral Tetrahydrouridine in Patients With Advanced Solid Tumors", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"4", :nct_id=>"NCT01587040", :pi_name=>"Agustin Garcia", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/4", :title=>"1B-12-5-International, Multicenter, Open-Label, Treatment-Extension Study for Subjects who Completed a Phase 1 or Phase 2 Parental Study to Continue Receiving Treatment with SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"286", :nct_id=>"NCT02079181", :pi_name=>"Peter Conti", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/286", :title=>"18F-FMAU for Imaging in Cancer Patients", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"317", :nct_id=>"NCT00719303", :pi_name=>"David Alberts", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/317", :title=>"Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?", :hashtags=>["#GynCSM"], :disease=>"Gynaecological Cancer"},
  {:initial_database_id=>"289", :nct_id=>"NCT01325441", :pi_name=>" ", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/289", :title=>"A Phase Ib/II Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"293", :nct_id=>"NCT01642342", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/293", :title=>"A First-In-Human Phase I Study of sEphB4-HSA in Patients With Advanced Solid Tumors With Expansion at the Maximum Tolerated Dose (MTD) or Recommended Phase II Dose (RP2D).", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"25", :nct_id=>"NCT01457118", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/25", :title=>"0C-12-4-An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled In NKTR-102 Studies", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"26", :nct_id=>"NCT01653470", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/26", :title=>"0C-12-6-A Phase Ib Ascending Multi-arm, Dose Escalation Study of BMS-906024 Combined with Several Chemotherapy Regimens in Subjects with Advanced or Metastatic Tumors", :hashtags=>["#Cancer", "#Tumor"], :disease=>"Cancer"},
  {:initial_database_id=>"269", :nct_id=>"NCT02150967", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/269", :title=>"3GB-14-1: A phase II multicenter, single arm study of oral BGJ398 in adult patients with advanced or metastatic  cholangiocarcinoma with FGFR2 gene fusions or other FGFR genetic alterations who failed or are intolerant to platinum-based chemotherapy", :hashtags=>["#BileDuctCancer"], :disease=>"Bile Duct Cancer"},
  {:initial_database_id=>"213", :nct_id=>"NCT01101451", :pi_name=>"Huyen Pham", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/213", :title=>"GOG 0263:  RANDOMIZED PHASE III CLINICAL TRIAL OF ADJUVANT RADIATION VERSUS CHEMORADIATION IN INTERMEDIATE RISK, STAGE I/IIA CERVICAL CANCER TREATED WITH INITIAL RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY", :hashtags=>["#CervicalCancer", "#GynCSM"], :disease=>"Cervical Cancer"},
  {:initial_database_id=>"76", :nct_id=>"NCT01545076", :pi_name=>"Said Beydoun", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/76", :title=>"Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investigate the efficacy, safety, and tolerability of 2 different doses of IgPro20 (subcutaneous immunoglobulin) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)  the PATH study\r\n\r\n", :hashtags=>["#CIDP"], :disease=>"CIDP"},
  {:initial_database_id=>"304", :nct_id=>"NCT02057991", :pi_name=>"Jane Figueiredo", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/304", :title=>"A Mindfulness-Based Educational Intervention For Colorectal Cancer Patients And Caregivers", :hashtags=>["#ColonCancer", "#RectalCancer", "#BowelCancer", "#CRCSM", "#LynchSyndrome"], :disease=>"Colon Cancer"},
  {:initial_database_id=>"65", :nct_id=>"NCT01719380", :pi_name=>"Heinz-Josef Lenz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/65", :title=>"3C-12-5-A Phase Ib/II Multi-Center, Open-Label, Dose Escalation Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in Patients with BRAF Mutant Metastatic Colorectal Cancer", :hashtags=>["#ColonCancer", "#RectalCancer", "#BowelCancer", "#CRCSM", "#LynchSyndrome"], :disease=>"Colon Cancer"},
  {:initial_database_id=>"246", :nct_id=>"NCT01416688", :pi_name=>"Heinz-Josef Lenz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/246", :title=>"SWOG-S1013:  A Prospective Study of Epidermal Growth Factor Receptor (HER-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy-EGFRI 18 (FACT-EGFRI 18) Questionnaire for EGFRI-Induced Skin Toxicities", :hashtags=>["#ColonCancer", "#RectalCancer", "#BowelCancer", "#CRCSM", "#LynchSyndrome"], :disease=>"Colon Cancer"},
  {:initial_database_id=>"45", :nct_id=>"NCT01349881", :pi_name=>"Syma Iqbal", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/45", :title=>"SWOG-S0820:  A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III-Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)", :hashtags=>["#ColonCancer", "#RectalCancer", "#BowelCancer", "#CRCSM", "#LynchSyndrome"], :disease=>"Colon Cancer"},
  {:initial_database_id=>"127", :nct_id=>"NCT02060188", :pi_name=>"Bristol-Myers Squibb", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/127", :title=>"A Phase 2 Clinical Trial of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Microsatellite High (MSI-H) Colon Cancer", :hashtags=>["#ColonCancer", "#RectalCancer", "#BowelCancer", "#CRCSM", "#LynchSyndrome"], :disease=>"Colon Cancer"},
  {:initial_database_id=>"143", :nct_id=>"NCT01871571", :pi_name=>"Afsaneh Barzi", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/143", :title=>"3R-12-2 Phase II Trial Of Neoadjuvant Bevacizumab With Modified FOLFOX7  In Patients With Stage II And III Rectal Cancer", :hashtags=>["#ColonCancer", "#RectalCancer", "#BowelCancer", "#CRCSM", "#LynchSyndrome"], :disease=>"Colon Cancer"},
  {:initial_database_id=>"221", :nct_id=>"NCT01543620", :pi_name=>"Paul Beringer", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/221", :title=>"PROSPECTIVE EVALUATION OF BIOMARKERS OF AMINOGLYCOSIDE NEPHROTOXICITY IN ADULT PATIENTS WITH CYSTIC FIBROSIS", :hashtags=>["#CysticFibrosis", "#curecf", "#cfaware"], :disease=>"Cystic Fibrosis"},
  {:initial_database_id=>"34", :nct_id=>"NCT01729286", :pi_name=>"Karen Woo", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/34", :title=>"A MULTI-CENTER, PROSPECTIVE, RANDOMIZED STUDY WITHPRIMATRIX DERMAL REPAIR SCAFFOLD MOIST WOUND THERAPYAND STANDARD OF CARE MOIST WOUND THERAPY FOR THETREATMENT OF CHRONIC DIABETIC FOOT ULCERS", :hashtags=>["#Diabetes"], :disease=>"Diabetes"},
  {:initial_database_id=>"210", :nct_id=>"NCT01730170", :pi_name=>"Laura Kalayjian", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/210", :title=>"Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs", :hashtags=>["#Epilepsy", "#Seizures"], :disease=>"Epilepsy"},
  {:initial_database_id=>"336", :nct_id=>"NCT01935934", :pi_name=>"Neesha Dhani", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/336", :title=>"A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer", :hashtags=>["#GynCSM"], :disease=>"Endometrial Cancer"},
  {:initial_database_id=>"231", :nct_id=>"NCT01940185", :pi_name=>"John Lipham ", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/231", :title=>"A PostApproval Study of the LINX Reflux Management System", :hashtags=>["#Heartburn", "#GERD"], :disease=>"Heartburn"},
  {:initial_database_id=>"31", :nct_id=>"NCT01586910", :pi_name=>"Vaughn Starnes", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/31", :title=>"Medtronic CoreValve SURTAVI Trial -Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)", :hashtags=>["#HeartDisease", "#HeartFailure", "#HeartHealth", "#CongestiveHeartFailure", "#SCADheart"], :disease=>"Heart Disease"},
  {:initial_database_id=>"270", :nct_id=>"NCT02099942", :pi_name=>"Ray Matthews", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/270", :title=>"Protocol #1058-001: Transluminal Aortic Balloon valvuloplasty Registry (TAB-R)", :hashtags=>["#HeartDisease", "#HeartFailure", "#HeartHealth", "#CongestiveHeartFailure", "#SCADheart"], :disease=>"Heart Disease"},
  {:initial_database_id=>"63", :nct_id=>"NCT01757665", :pi_name=>"Vaughn Starnes", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/63", :title=>"ProspeCtive, nOnrandoMized, MulticENter Clinical evaluation of the Edwards Pericardial Aortic Bioprosthesis, Model 11000A with a new tissue treatment platform (COMMENCE TRIAL)", :hashtags=>["#HeartDisease", "#HeartFailure", "#HeartHealth", "#CongestiveHeartFailure", "#SCADheart"], :disease=>"Heart Disease"},
  {:initial_database_id=>"292", :nct_id=>"NCT02131025", :pi_name=>"GSK Trials", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/292", :title=>"201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.", :hashtags=>["#HIV", "#AIDS"], :disease=>"HIV"},
  {:initial_database_id=>"190", :nct_id=>"NCT01196390", :pi_name=>"Heinz-Josef Lenz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/190", :title=>"RTOG-1010  A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of Her2-Overexpressing Esophageal Adenocarcinoma", :hashtags=>["#HNCsm", "#HeadNeckCancer"], :disease=>"Throat Cancer"},
  {:initial_database_id=>"11", :nct_id=>"NCT01836029", :pi_name=>"Barbara Gitlitz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/11", :title=>"7H-13-2-A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination with VTX-2337 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck", :hashtags=>["#HNCsm", "#HeadNeckCancer"], :disease=>"Head Cancer"},
  {:initial_database_id=>"259", :nct_id=>"NCT01841736", :pi_name=>"Syma Iqbal", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/259", :title=>"CTSU/CALGB A021202: Prospective Randomized Phase II Trial Of Pazopanib (NSC # 737754, IND 75648) Versus Placebo In Patients With Progressive Carcinoid Tumors", :hashtags=>["#HNCsm", "#HeadNeckCancer"], :disease=>"Head Cancer"},
  {:initial_database_id=>"176", :nct_id=>"NCT00956007", :pi_name=>"Eugene Chung", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/176", :title=>"RTOG 0920 - A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER", :hashtags=>["#HNCsm", "#HeadNeckCancer"], :disease=>"Head Cancer"},
  {:initial_database_id=>"106", :nct_id=>"NCT01679132", :pi_name=>"Karen Woo", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/106", :title=>"Barostim  Hypertension Pivotal Trial", :hashtags=>["#Hypertension", "#HighBloodPressure"], :disease=>"Hypertension"},
  {:initial_database_id=>"74", :nct_id=>"NCT01389206", :pi_name=>"Sivagini Ganesh", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/74", :title=>"Pulmonary Arterial Hypertension (PAH) Quality Enhancement Research Initiative (QuERI) Extension Program", :hashtags=>["#Hypertension", "#HighBloodPressure"], :disease=>"Hypertension"},
  {:initial_database_id=>"284", :nct_id=>"NCT01227967", :pi_name=>"John Beigel", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/284", :title=>"A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications", :hashtags=>["#Influenza"], :disease=>"Influenza"},
  {:initial_database_id=>"310", :nct_id=>"NCT01575548", :pi_name=>"Leonard Appleman", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/310", :title=>"Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy", :hashtags=>["#KidneyCancer", "#KidneyDisease", "#kcsm"], :disease=>"Kidney Cancer"},
  {:initial_database_id=>"157", :nct_id=>"NCT01038778", :pi_name=>"David Quinn", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/157", :title=>"4K-12-2 PH I-71 Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination with the Histone Deacetylase Inhibitor Entinostat in Patients with Metastatic Renal Cell Carcinoma", :hashtags=>["#KidneyCancer", "#KidneyDisease", "#kcsm"], :disease=>"Kidney Cancer"},
  {:initial_database_id=>"193", :nct_id=>"NCT01664182", :pi_name=>"David Quinn", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/193", :title=>"4K-13-1 PhII-122 A Randomized Phase 2 Study of AMG 386 with or without Continued Anti-Vascular Endothelial Growth Factor (VEGF) Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib", :hashtags=>["#KidneyCancer", "#KidneyDisease", "#kcsm"], :disease=>"Kidney Caner"},
  {:initial_database_id=>"79", :nct_id=>"NCT02110901", :pi_name=>"Vincent Rowe", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/79", :title=>"Multicenter, Double-Blind, Placebo-Controlled Study of PRT-201 Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease", :hashtags=>["#KidneyDisease"], :disease=>"Kidney Disease"},
  {:initial_database_id=>"47", :nct_id=>"NCT01820572", :pi_name=>"Yasir Qazi", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/47", :title=>"Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix (belatacept)-based Immunosuppression ", :hashtags=>["#KidneyDisease", "#Transplant"], :disease=>"Kidney Disease"},
  {:initial_database_id=>"95", :nct_id=>"NCT01794663", :pi_name=>"Linda Sher", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/95", :title=>"A Three-Part, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Sequential Adaptive, Phase II Study to Evaluate the Safety, Tolerability and Efficacy of OPN305, a Humanised Monoclonal Antibody that Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function", :hashtags=>["#KidneyDisease", "#Transplant"], :disease=>"Kidney Disease"},
  {:initial_database_id=>"311", :nct_id=>"NCT01564784", :pi_name=>" ", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/311", :title=>"An Open-label, Randomized Phase 3 Study Of Inotuzumab Ozogamicin Compared To A Defined Investigator's Choice In Adult Patients With Relapsed Or Refractory Cd22-positive Acute Lymphoblastic Leukemia (All)", :hashtags=>["#Leukemia", "#leusm", "#neutropenia", "#XMRV"], :disease=>"Leukemia"},
  {:initial_database_id=>"244", :nct_id=>"NCT01801046", :pi_name=>"Ann Mohrbacher", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/244", :title=>"9L-11-8: HLA-mismatched allogeneic cellular therapy (HMMACT) after Chemotherapy in  High Risk Acute Myeloid Leukemia", :hashtags=>["#Leukemia", "#leusm", "#neutropenia", "#XMRV"], :disease=>"Leukemia"},
  {:initial_database_id=>"288", :nct_id=>"NCT01593254", :pi_name=>"Bristol-Myers Squibb", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/288", :title=>"An Open Label, Randomized (2:1) Phase IIb Study of Dasatinib Versus Imatinib in Patients With Chronic Phase Chronic Myeloid Leukemia Who Have Not Achieved an Optimal Response to 3 Months of Therapy With 400 mg Imatinib", :hashtags=>["#Leukemia", "#leusm", "#neutropenia", "#XMRV"], :disease=>"Leukemia"},
  {:initial_database_id=>"257", :nct_id=>"NCT01404949", :pi_name=>"Vinod Pullarkat", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/257", :title=>"9L-12-1: Phase II Study of Combined Tretinoin and Arsenic Trioxide for Patients with Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy", :hashtags=>["#Leukemia", "#leusm", "#neutropenia", "#XMRV"], :disease=>"Leukemia"},
  {:initial_database_id=>"312", :nct_id=>"NCT01658878", :pi_name=>"Bristol-Myers Squibb", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/312", :title=>"A Phase I Dose Escalation Study to Investigate the Safety, Immunoregulatory Activity, Pharmacokinetics, and Preliminary Antitumor Activity of Anti-Programmed-Death-1 (PD-1) Antibody (BMS-936558) in Advanced Hepatocellular Carcinoma in Subjects With or Without Chronic Viral Hepatitis", :hashtags=>["#LiverCancer", "#LiverDisease"], :disease=>"Liver Cancer"},
  {:initial_database_id=>"109", :nct_id=>"NCT01908426", :pi_name=>"Anthony El-Khoueiry", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/109", :title=>"3L-13-3-A Phase 3, Randomized, Double-blind, Controlled Study of  Cabozantinib (XL184) vs Placebo in   Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib\r\n", :hashtags=>["#LiverCancer", "#LiverDisease"], :disease=>"Liver Cancer"},
  {:initial_database_id=>"248", :nct_id=>"NCT01846663", :pi_name=>"Linda Sher", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/248", :title=>"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF RIFAXIMIN 550 MG IN SUBJECTS WITH SEVERE HEPATIC IMPAIRMENT AND OVERT HEPATIC ENCEPHALOPATHY", :hashtags=>["#LiverDisease"], :disease=>"Liver Disease"},
  {:initial_database_id=>"120", :nct_id=>"NCT01804829", :pi_name=>"Linda Sher", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/120", :title=>"A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir, in Orthotopic Liver Transplant Recipients", :hashtags=>["#LiverDisease", "#Transplant"], :disease=>"Liver Disease"},
  {:initial_database_id=>"330", :nct_id=>"NCT01935947", :pi_name=>"Julie Brahmer", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/330", :title=>"A Randomized Phase II Trial of Cytotoxic Chemotherapy With or Without Epigenetic Priming in Patients With Advanced Non-small Cell Lung Cancer", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"267", :nct_id=>"NCT02273336", :pi_name=>"Barbara Gitlitz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/267", :title=>"2L-14-1 Genomics of Young Lung Cancer Study", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"144", :nct_id=>"NCT01526928", :pi_name=>"Barbara Gitlitz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/144", :title=>"2N-13-7: A Phase 1/2, Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral CO-1686 in Patients with Previously Treated Mutant EGFR Non-Small Cell Lung Cancer (NSCLC)", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"159", :nct_id=>"NCT01064648", :pi_name=>"Barbara Gitlitz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/159", :title=>"SWOG-S0905: A Phase I/Randomized Phase II Study of Cediranib (NSC # 732208) versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"36", :nct_id=>"NCT01336634", :pi_name=>"Barbara Gitlitz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/36", :title=>"2N-12-5: A Phase II study of the BRAF inhibitor dabrafenib as a single agent and in combination with the MEK inhibitor trametinib in subjects with BRAF V600E mutation positive metastatic (stage IV) non-small cell lung cancer", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"183", :nct_id=>"NCT02250378", :pi_name=>"Eugene Chung", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/183", :title=>"2N-14-3: Feasibility Study of Stereotactic Body Radiation Therapy Followed by Wedge Resection for Peripherally Located Early Stage Non-Small Cell Lung Cancer", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"260", :nct_id=>"NCT02154490", :pi_name=>"Jorge Nieva", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/260", :title=>"Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer", :hashtags=>["#LungCancer", "#WhipLungCancer", "#WorldLungCancerDay"], :disease=>"Lung Cancer"},
  {:initial_database_id=>"195", :nct_id=>"NCT01729806", :pi_name=>"Ann Mohrbacher", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/195", :title=>"13NHL-12-1:  PHI-69 A Phase I Study of Ipilimumab in Combination with Rituximab in Patients with Relapsed/Refractory CD20+ B-Cell Lymphoma\r\n", :hashtags=>["#Lymphoma", "#BloodCancer"], :disease=>"Lymphoma"},
  {:initial_database_id=>"197", :nct_id=>"NCT01567709", :pi_name=>"Kevin Kelly", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/197", :title=>"0S-11-12: PhI-67  Phase I Study of the Aurora Kinase A Inhibitor MLN8237 in Combination with the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies", :hashtags=>["#Lymphoma", "#BloodCancer"], :disease=>"Lymphoma"},
  {:initial_database_id=>"75", :nct_id=>"NCT00940602", :pi_name=>"Vinod Pullarkat", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/75", :title=>"9L-11-2:  A Multi-Center, Randomized, Double-Blind, Placebocontrolled Clinical Trial of Deferasirox in Patients with Myelodysplastic Syndromes (Low/Int-1 Risk) and Transfusional Iron Overload (TELESTO) CICL670A2302", :hashtags=>["#MDS"], :disease=>"MDS"},
  {:initial_database_id=>"332", :nct_id=>"NCT01903811", :pi_name=>"Sikander Ailawadhi", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/332", :title=>"S1304, A Phase II Randomized Study Comparing Two Doses of Carfilzomib (NSC-756640) With Dexamethasone for Multiple Myeloma Patients With Relapsed or Refractory Disease", :hashtags=>["#Myeloma", "#MMSM"], :disease=>"Myeloma"},
  {:initial_database_id=>"27", :nct_id=>"NCT01959139", :pi_name=>"Syma Iqbal", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/27", :title=>"SWOG-S1313: A Phase Ib/II Randomized Study of Modified FOLFIRINOX + Pegylated Recombinant Human Hyaluronidase (PEGPH20) versus Modified FOLFIRINOX Alone in Patients with Good Performance Status Metastatic Pancreatic Adenocarcinoma.", :hashtags=>["#PancreaticCancer", "#pancsm"], :disease=>"Pancreatic Cancer"},
  {:initial_database_id=>"64", :nct_id=>"NCT02050178", :pi_name=>"Heinz-Josef Lenz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/64", :title=>"3P-13-3: A Phase 1b Dose Escalation Study of OMP-54F28 in Combination with Nab-Paclitaxel and   Gemcitabine in Patients with Previously Untreated Stage IV Pancreatic Cancer  ", :hashtags=>["#PancreaticCancer", "#pancsm"], :disease=>"Pancreatic Cancer"},
  {:initial_database_id=>"247", :nct_id=>"NCT01764477", :pi_name=>"Heinz-Josef Lenz", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/247", :title=>"3P-12-1: Phase IbMulticenter, Cohort Dose Escalation Trial to Determine the Safety, Tolerance and Preliminary Antineoplastic Activity of Gemcitabine Administered in Combination with Continuous Intravenous Doses of PRI-724, a CBP/ - Catenin Inhibitor, to Patients with Advanced or Metastatic Pancreatic Adenocarcinoma Eligible for Second-Line Therapy After Failing First-Line Therapy with FOLFIRINOX(or FOLFOX)", :hashtags=>["#PancreaticCancer", "#pancsm"], :disease=>"Pancreatic Cancer"},
  {:initial_database_id=>"126", :nct_id=>"NCT02217709", :pi_name=>"Mitchell Gross", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/126", :title=>"Phase 2 Trial of phenelzine in non-metastatic recurrent prostate cancer", :hashtags=>["#ProstateCancer", "#PCSM"], :disease=>"Prostate Cancer"},
  {:initial_database_id=>"145", :nct_id=>"NCT02034552", :pi_name=>"David Quinn", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/145", :title=>"4P-13-8: A randomized open-label phase IIa study evaluating quantified bone scan response following treatment with radium-223 dichloride alone or in combination with abiraterone acetate or enzalutamide in subjects with castration-resistant prostate cancer who have bone metastases", :hashtags=>["#ProstateCancer", "#PCSM"], :disease=>"Prostate Cancer"},
  {:initial_database_id=>"334", :nct_id=>"NCT01909440", :pi_name=>"E. Schroeder", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/334", :title=>"Exercise and Whey Protein Supplementation as Adjunctive Therapy for Patients With Prostate Cancer Receiving Androgen Deprivation Therapy", :hashtags=>["#ProstateCancer", "#PCSM"], :disease=>"Prostate Cancer"},
  {:initial_database_id=>"316", :nct_id=>"NCT00936390", :pi_name=>"Alvaro Martinez", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/316", :title=>"A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer", :hashtags=>["#ProstateCancer", "#PCSM"], :disease=>"Prostate Cancer"},
  {:initial_database_id=>"318", :nct_id=>"NCT01809691", :pi_name=>"Neeraj Agarwal", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/318", :title=>"A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer", :hashtags=>["#ProstateCancer", "#PCSM"], :disease=>"Prostate Cancer"},
  {:initial_database_id=>"23", :nct_id=>"NCT00695214", :pi_name=>"Eric Kezirian", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/23", :title=>"Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea", :hashtags=>["#SleepApnea", "#SleepDisorder", "#SleepHealth", "#Narcolepsy"], :disease=>"Sleep Apnea"},
  {:initial_database_id=>"172", :nct_id=>"NCT02207127", :pi_name=>"Eric Kezirian", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/172", :title=>"Magnetic Resonance Imaging in Obstructive Sleep Apnea", :hashtags=>["#SleepApnea", "#SleepDisorder", "#SleepHealth", "#Narcolepsy"], :disease=>"Sleep Apnea"},
  {:initial_database_id=>"20", :nct_id=>"NCT01450696", :pi_name=>"Syma Iqbal", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/20", :title=>"3G-11-3-A Randomized, Open-Label, Multicenter Phase IIIB Study Comparing Two Trastuzumab Dosing Regimens, Each  in Combination with Cisplatin/Capecitabine Chemotherapy, as First-Line Therapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Adenocarcinoma who have not Received Prior Treatment for Metastatic Disease.", :hashtags=>["#StomachCancer", "#stcsm"], :disease=>"Stomach Cancer"},
  {:initial_database_id=>"277", :nct_id=>"NCT02300987", :pi_name=>"David Quinn", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/277", :title=>"0S-14-5: A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients with Relapsed, Refractory, Incurable Teratoma with Recent Progression", :hashtags=>["#Teratoma"], :disease=>"Teratoma"},
  {:initial_database_id=>"325", :nct_id=>"NCT01208051", :pi_name=>"Jonas Souza", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/325", :title=>"Phase I/II Trial of Cediranib Alone or Cediranib and Lenalidomide in Iodine 131-Refractory Differentiated Thyroid Cancer", :hashtags=>["#ThyroidCancer", "#thycsm", "#thyroidawareness"], :disease=>"Thyroid Cancer"},
  {:initial_database_id=>"62", :nct_id=>"NCT01701362", :pi_name=>"Said Beydoun", :url=>"http://clinicaltrials.keckmedicine.org/clinicaltrials/62", :title=>"A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PARALLEL\r\nGROUP STUDY OF THE EFFICACY AND SAFETY OF PREGABALIN (BID) IN\r\nSUBJECTS WITH POST-TRAUMATIC PERIPHERAL NEUROPATHIC PAIN", :hashtags=>["#TrigeminalNeuralgia", "#FacialPain"], :disease=>"Neuralgia"}
)
# End auto-generated file.
